Breast cancer (BC) is a heterogeneous disease classified into the following molecular subtypes: estrogen receptor positive α (ERα), epidermal growth factor receptor 2 positive (HER2+), and triple negative (TNBC) [1]. This evidence concerns the gene ERBB2 and breast cancer.